11 billion compounds available for your research at Chemspace

webinar

Mon, 28 Oct 2019, 16:00 CET (Berlin)

Dr. Yurii S. Moroz, CEO of Chemspace, Riga, Latvia

11 billion compounds available for your research at Chemspace

Chemspace just renewed its claim to be the largest online resource for small molecules. Including the REAL Space with more than 11 billion virtual product molecules provided on demand by Enamine, Chemspace again outnumbers all other small molecule resources by orders of magnitude. The success of your project depends on choosing the right source of molecules and medicinal chemistry expertise. At Chemspace, we understand your needs and guarantee molecules delivery in the required amount with high purity and always on time. Close collaboration with our respectful suppliers including Enamine, FCH group, and UORSY, among others, allows us to achieve this goal. In this webinar you’ll learn what Chemspace offers, how we work and why Chemspace stands out as the premier provider of high-quality drug discovery solutions.

Current news

"A Gaze into Chemical Space" Series
April 16, 2024 11:26 CEST
Introducing our latest series, “A Gaze into Chemical Space,” where we explore the expansive realms of combinatorial compound collections. Our aim in this exercise is to uncover similar compounds of potential and approved drugs using various methods. Typically, several synthesis steps are required to get to a compound with favorable...
Read on
Behind the Scenes of Enamine's REAL Space
April 15, 2024 16:43 CEST
Since its launch in 2018, Enamine’s REAL Space has made a significant impact in revolutionizing the landscape of compound collections. The initial version contained approximately 650 million compounds, establishing itself as one of the expansive catalogs of commercially available molecules for drug discovery. Notably, the first release rivaled even the...
Read on
category
Challenge
Martin Schwalm Emerges as Winner of Scientific Challenge Spring 2023
March 15, 2024 14:44 CET
The Scientific Challenge Spring 2023 comes to a conclusion: Martin Schwalm from the University of Frankfurt wins with his project “Identifying Binders to Hijack the Autophagy System for Targeted Protein Degradation”! The study aimed to identify binders for the LC3A protein’s hydrophobic binding site, a crucial target for drug discovery...
Read on